Board Committee change

RNS Number : 3147V

GlaxoSmithKline PLC

11 December 2013

 



Board Committee change

GlaxoSmithKline plc announces that Lynn Elsenhans, a Non-Executive Director, has been appointed as a member of the Audit & Risk Committee with effect from 1 January 2014.

Sonja Arsenić 

Corporate Secretariat

11 December 2013

 

END

 

 

BOAUAOVRORAUAAA